QQ客服 官方微博 反馈留言

	Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia
	Taub, Jeffrey W.; Luedtke, Daniel A.; Su, Yongwei; Edwards, Holly; Polin, Lisa; Kushner, Juiwanna; Dzinic, Sijana H.; Lin, Hai; Ge, Yubin
刊名	BLOOD
	2018
卷号	132
ISSN号	0006-4971
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3534505
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Taub, Jeffrey W.,Luedtke, Daniel A.,Su, Yongwei,et al. Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia[J]. BLOOD,2018,132.
APA	Taub, Jeffrey W..,Luedtke, Daniel A..,Su, Yongwei.,Edwards, Holly.,Polin, Lisa.,...&Ge, Yubin.(2018).Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia.BLOOD,132.
MLA	Taub, Jeffrey W.,et al."Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia".BLOOD 132(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。